Physician profile
Danielle Mccormack
NPI 1568870913
$12,664.37
in general payments reported to CMS, 2019-2025
10 companies · $1,311 in 2025
The $1,311 reported for 2025 was more than what 96% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $741 · 2020: $191 · 2021: $7,386 · 2022: $127 · 2023: $36.71 · 2024: $2,871 · 2025: $1,311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,924 · Travel and Lodging: $1,583 · Education: $712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,923.88 |
| Travel and Lodging | $1,583.14 |
| Education | $711.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salvin Dental Specialties, INC. | $6,550.22 | 2021 | |
| Zimvie INC. | $3,179.80 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $1,344.18 | 2019-2021 | |
| Hu-Friedy Mfg. Co., LLC | $725.22 | 2019-2025 | Hu-Friedy Power Air & Piezo Unit |
| Keystone Dental INC. | $332.67 | 2019-2024 | |
| Geistlich Pharma, North America, INC. | $327.79 | 2021 | |
| Biohorizons Implant Systems INC. | $77.56 | 2022 | |
| Solventum Corporation | $71.81 | 2025 | 3m Clinpro |
| Abbott Laboratories | $33.15 | 2024 | |
| Daiichi Sankyo INC. | $21.97 | 2024 | Injectafer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Mccormack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.